<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Spark Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Spark Therapeutics, Inc.

    Spark Therapeutics, a fully integrated company, strives to challenge the inevitability of genetic disease by working to discover, develop and deliver gene therapies that address inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $352,000,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Jeffrey D. Marrazzo
    • FOUNDED
      2013
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Vanda Pharmaceuticals Inc.

    Vanda Pharmaceuticals Inc.

    Vanda is developing important new medicines to improve the lives of patients. We u...

    Vanda is developing important new medicines to ...

    Filing Type:    PU
    Entasis Therapeutics Holdings Inc.

    Entasis Therapeutics Holdings Inc.

    Entasis is a clinical-stage biopharmaceutical company focused on the discovery, de...

    Entasis is a clinical-stage biopharmaceutical c...

    Filing Type:    PU
    Trinity Biotech plc

    Trinity Biotech plc

    Trinity Biotech specializes in the development, manufacture and marketing of diagn...

    Trinity Biotech specializes in the development,...

    Filing Type:    PU
    Unum Therapeutics Inc.

    Unum Therapeutics Inc.

    Unum Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Unum Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    AC Immune SA

    AC Immune SA

    We are a clinical stage biopharmaceutical company leveraging our two proprietary t...

    We are a clinical stage biopharmaceutical compa...

    Filing Type:    PU
    Redhill Biopharma Ltd.

    Redhill Biopharma Ltd.

    RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) is a special...

    RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv...

    Filing Type:    PU
    uniQure N.V.

    uniQure N.V.

    uniQure is delivering on the promise of gene therapy -- single treatments with pot...

    uniQure is delivering on the promise of gene th...

    Filing Type:    PU
    Tocagen Inc.

    Tocagen Inc.

    Tocagen is a clinical-stage, cancer-selective gene therapy company developing firs...

    Tocagen is a clinical-stage, cancer-selective g...

    Filing Type:    PU
    Fortress Biotech, Inc.

    Fortress Biotech, Inc.

    Fortress Biotech ("Fortress" or "the Company") is an innovative biopharmaceutical ...

    Fortress Biotech ("Fortress" or "the Company") ...

    Filing Type:    PU
    BridgeBio Pharma, Inc.

    BridgeBio Pharma, Inc.

    BridgeBio finds, develops, and delivers breakthrough medicines for genetic disease...

    BridgeBio finds, develops, and delivers breakth...

    Filing Type:    PU
    Stoke Therapeutics, Inc.

    Stoke Therapeutics, Inc.

    Stoke is pioneering a new way to treat the underlying cause of severe genetic dise...

    Stoke is pioneering a new way to treat the unde...

    Filing Type:    PU
    Synlogic, Inc.

    Synlogic, Inc.

    Synlogic™ is pioneering the development of a novel class of living Synthetic Bio...

    Synlogic™ is pioneering the development of a ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.